08:40pm Wednesday 20 September 2017

Chaos in cell division – How chromosomal defects arise in cancer cells

Cancer cells often have aberrant numbers of chromosomes. Scientists from the German Cancer Research Center have now discovered a new mechanism that plays a role in these typical chromosomal aberrations. The new findings question the current concept of how cancer cells survive the chaos during cell division. This might also make it necessary to rethink specific treatment approaches that interfere with the distribution of chromosomes.

Cell division with surplus centrioles at both spindle poles. The upper panel  is a light-microscopy image; the lower panel is an electron microscopy-based (FIB/SEM) 3D reconstruction of a mitotic cell. © Alwin Krämer/DKFZ

When cells divide, the newly duplicated set of chromosomes is distributed evenly to the two newly forming daughter cells. This process is regulated by two polar bodies called centrosomes. Between the two centrosomes, protein fibers arise that appear like a spindle-shaped structure under the microscope. Along these fibers, one chromosome set each is pulled towards one of the poles. This normally ensures that each daughter cell is fully equipped. In cancer cells, however, scientists often observe higher or lower numbers of chromosomes than normal. This can be attributed to uneven distribution during cell division.

One reason for this faulty distribution has been known for some time: Cancer cells often exhibit more than two centrosomes. In order to avoid total chaos in cell division, the extra centrosomes often form clusters. This ensures, at least, that only two daughter cells form instead of several. However, the chromosomes can still be distributed aberrantly. “Up to now, we have assumed that clustering helps tumor cells survive,” said Alwin Krämer, who pursues research at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and Heidelberg University Hospital. “But our investigations show that many of these cells die nevertheless.” Therefore, the cause of aberrations in the distribution of chromosomes in tumors must be sought earlier on.

In collaboration with colleagues from the European Molecular Biology Laboratory (EMBL), Heidelberg, Krämer and his co-workers took a closer look at the replication of centrosomes. Every time a cell divides, the polar bodies must also duplicate in order to ensure that each daughter cell will later be equipped with two copies. Each centrosome normally consists of two centrioles, cylindrical protein structures that form a kind of centerpiece. After every cell division, only one new daughter centriole forms at each centriole, resulting in the formation of two new polar bodies in both daughter cells.

Krämer and his co-workers discovered that many things can already go wrong in this step. Experiments in the Petri dish showed that cancer cells frequently form not only one daughter centriole but a couple of them. “This lays the foundation for the formation of more than two centrosomes in the next cell division,” explains Krämer. “In addition, if the two polar bodies contain different numbers of centrioles, this causes an imbalance in cell division that also results in faulty distribution of chromosomes.” The polar body with the higher number of centrioles will also pull more chromosomes towards it; their correct distribution is no longer ensured.

“Interestingly, we observe that cancer cells with chromosomal aberrations that are a result of too many centrioles survive and form part of the tumor mass,” Krämer said. By contrast, cells whose chromosomal defect is based on additional centrosomes often die. “This also sheds new light on tumor therapy”, the scientist added. More recent therapy approaches have attempted to prevent clustering of extra centrosomes in order to produce chaos in the chromosomal distribution and thus to prevent survival of the daughter cells. “If it proves true that the typical chromosomal aberrations in tumors arise through a different mechanism, we also need to search for new therapy approaches,” Krämer summed up.

Marco R. Cosenza, Anna Cazzola, Annik Rossberg, Nicole L. Schieber, Gleb Konotop, Elena Bausch, Alla Slynko, Tim Holland-Letz, Marc S. Raab, Taronish Dubash, Hanno Glimm, Sven Poppelreuther, Christel Herold-Mende, Yannick Schwab and Alwin Krämer: Asymmetric Centriole Numbers at Spindle Poles Cause Chromosome Missegregation in Cancer. Cell Reports 2017 DOI: 10.1038/onc.2012.310

A picture is available at:
http://www.dkfz.de/de/presse/pressemitteilungen/2017/bilder/Cosenza-et-al-COVER.jpg
Caption: Cell division with surplus centrioles at both spindle poles. The upper panel  is a light-microscopy image; the lower panel is an electron microscopy-based (FIB/SEM) 3D reconstruction of a mitotic cell.

Note on use of images related to press releases
Use is free of charge. The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) permits one-time use in the context of reporting about the topic covered in the press release. Images have to be cited as follows: “Source: Alwin Krämer/DKFZ”.
Distribution of images to third parties is not permitted unless prior consent has been obtained from DKFZ’s Press Office (phone: ++49-(0)6221 42 2854, E-mail: presse@dkfz.de). Any commercial use is prohibited.

The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) with its more than 3,000 employees is the largest biomedical research institute in Germany. At DKFZ, more than 1,000 scientists investigate how cancer develops, identify cancer risk factors and endeavor to find new strategies to prevent people from getting cancer. They develop novel approaches to make tumor diagnosis more precise and treatment of cancer patients more successful. The staff of the Cancer Information Service (KID) offers information about the widespread disease of cancer for patients, their families, and the general public. Jointly with Heidelberg University Hospital, DKFZ has established the National Center for Tumor Diseases (NCT) Heidelberg, where promising approaches from cancer research are translated into the clinic. In the German Consortium for Translational Cancer Research (DKTK), one of six German Centers for Health Research, DKFZ maintains translational centers at seven university partnering sites. Combining excellent university hospitals with high-profile research at a Helmholtz Center is an important contribution to improving the chances of cancer patients. DKFZ is a member of the Helmholtz Association of National Research Centers, with ninety percent of its funding coming from the German Federal Ministry of Education and Research and the remaining ten percent from the State of Baden-Württemberg. 


Share on:
or:

Health news